Champions Oncology (CSBR) director awarded 21,216 options at $6.80

Champions Oncology (CSBR) director reported a stock option grant.

Rhea-AI Filing Summary

Champions Oncology (CSBR) director reported a stock option grant. On 11/05/2025, the reporting person received 21,216 options to purchase common stock at an exercise price of $6.80 per share, with an expiration date of 11/05/2035.

The options vest over twelve months in four equal installments on Nov 5, 2025, Feb 5, 2026, May 5, 2026, and Aug 5, 2026. Following the transaction, 21,216 derivative securities were beneficially owned, reported as Direct (D) ownership.

Insider Trade Summary

Grant/Award: 21,216 shares

Grant/Award 1 txn

Insider ACKERMAN JOEL

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase Common Stock	21,216	$6.80	$144K

Holdings After Transaction: Option to purchase Common Stock — 21,216 contracts (Direct)

Footnotes (1)

1. F1. The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Champions Oncology (CSBR) disclose in this Form 4?

A director reported receiving 21,216 stock options on 11/05/2025 at an exercise price of $6.80 per share.

What is the exercise price and expiry of the CSBR options?

The options have an exercise price of $6.80 and expire on 11/05/2035.

How do the CSBR options vest?

They vest over twelve months in four tranches on Nov 5, 2025, Feb 5, 2026, May 5, 2026, and Aug 5, 2026.

How many derivative securities were owned after the transaction?

21,216 derivative securities were beneficially owned following the reported transaction.

What is the ownership form reported for these CSBR options?

The filing lists Direct (D) ownership.

What role does the reporting person have at Champions Oncology (CSBR)?

The reporting person is a Director of Champions Oncology, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/07/2025 - 10:26 AM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ACKERMAN JOEL

(Last) (First) (Middle)

C/O CHAMPIONS ONCOLOGY, INC.

ONE UNIVERSITY PLACE, SUITE 307

(Street)

HACKENSACK NJ 07601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CHAMPIONS ONCOLOGY, INC. [ CSBR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase Common Stock	$6.8	11/05/2025		A		21,216		(1)	11/05/2035	Common Stock	21,216	$6.8	21,216	D

Explanation of Responses:

1. The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.

Remarks:

	/s/ Joel Ackerman	11/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.